Literature DB >> 28967279

Time to revisit warfarin pharmacogenetics.

Larisa H Cavallari1.   

Abstract

Entities:  

Keywords:  CYP2C9; VKORC1; genotype; pharmacogenetics; polymorphism; warfarin

Mesh：

Substances：

Year:  2017        PMID： 28967279     DOI： 10.2217/fca-2017-0061

Source DB:  PubMed          Journal:  Future Cardiol        ISSN： 1479-6678


× No keyword cloud information.
  3 in total

1.  Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease.

Authors:  Laith N Al-Eitan; Barakat Z Elsaqa; Ayah Y Almasri; Hatem A Aman; Rame H Khasawneh; Mansour A Alghamdi
Journal:  Pharmgenomics Pers Med       Date:  2020-11-17

2.  Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients.

Authors:  Jubby Marcela Galvez; Carlos Martin Restrepo; Nora Constanza Contreras; Clara Alvarado; Carlos-Alberto Calderón-Ospina; Nidia Peña; Ricardo A Cifuentes; Daniela Duarte; Paul Laissue; Dora Janeth Fonseca
Journal:  Pharmgenomics Pers Med       Date:  2018-10-16

3.  Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease.

Authors:  Mansour A Alghamdi; Laith Al-Eitan; Rami Alkhatib; Ahmad Al-Assi; Ayah Almasri; Hanan Aljamal; Hatem Aman; Rame Khasawneh
Journal:  Int J Gen Med       Date:  2021-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.